本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

23.89
+0.50502.16%
成交量:204.47萬
成交額:4,889.38萬
市值:29.87億
市盈率:110.88
高:24.18
開:23.63
低:23.55
收:23.38
52周最高:31.77
52周最低:16.57
股本:1.25億
流通股本:1.11億
量比:0.90
換手率:1.84%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
淨資產收益率:15.86%
總資產收益率:5.09%
市淨率:13.54
市盈率(LYR):-188.28

資料載入中...

2022/08/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/05

重要事件披露

8-K - Current report
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/02

重要事件披露

8-K - Current report
2022/06/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/09

重要事件披露

8-K - Current report
2022/06/02

重要事件披露

8-K - Current report
2022/05/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

重要事件披露

8-K - Current report
2022/04/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/03

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/22

重要事件披露

8-K - Current report
2022/02/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/23

重要事件披露

8-K - Current report
2021/12/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals